Zurück
  • Abstract lecture
  • AL015

Safety and tolerability of combining CGRP monoclonal antibodies with Gepants in patients with migraine: a retrospective study

Termin

Datum:
Zeit:
Redezeit:
Diskussionszeit:
Ort / Stream:
Plenary hall

Session

ScS 5 | The non-responders: It is not all about CGRP

Thema

  • The non-responders: It is not all about CGRP.
    • v1.21.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Impressum
    • Datenschutz